CellType
PrivateLast Round
Seed
Jan 1, 2026
Total Funding Raised
$500,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CellType operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in January 2026.
CellType is a life sciences and artificial intelligence company that has developed a biological reasoning engine to simulate drug responses in human biology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellType Comparables
Compare CellType with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GenBio AI | 85% | |
| Strand AI | 85% | |
| Tahoe Therapeutics | 85% |
For institutional investors. Book with your work email.
CellType Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CellType Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Fund | Seed |
| Founder Factor | Seed |
| Y Combinator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2026
Grew 100% QoQ from 3 to 6 employees.
- Jun 21, 2026
Monthly visitors grew 100% MoM, reaching 6.8K.
For institutional investors. Book with your work email.
CellType Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CellType's valuation, stock price, and market status.
Is CellType a public or private company?
CellType is a private company.
What is the current stock price of CellType?
CellType is a private company, so its shares have no public market price. Caplight tracks CellType's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CellType worth (valuation)?
Valuation information for CellType is not publicly available.
Can I buy CellType stock?
CellType shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CellType's last funding round?
CellType's most recent funding round was Seed on January 1, 2026.
Who are the main investors in CellType?
Key investors in CellType include Y Combinator.
Will CellType IPO soon?
No public IPO plans have been announced for CellType.
How can I track CellType secondary market activity?
Caplight tracks bids, offers, and trades in CellType's shares on secondary markets.